So I might have been a little 'aggressive' (as RedNeck stated) in my response for BiosectInvestor last night. I just got tired in people responding to my post when I specifically said I am not going to argue with anyone, if they have a different view. Plenty of posters have expressed a different view in posts without it being a response to my post. I think that is great, as we all have views on how the future will look.
I rarely post anything about NWBO and the science behind it as I am a trader. The post I made in regard to Flaskworks was not my idea. It was from a person who is watching the board, has direct knowledge from his work with NWBO and via that work was told before DL that this was their plan. With all the recent improvements to the Flaskworks device, he felt comfortable telling me that it looks like they are still working towards their goal from before DL. His views were then further collaborated to me from people who has experience with dendritic cell work from Dendreon and now other immunotherapy companies (one which is close to getting to the finish line with a skin cancer treatment :) )
Over the last 2 years I have come in contact with people who have worked with NWBO as independent contractors and people who are in the immunotherapy industry and I have yet to meet anyone who are not thrilled about the future of cancer treatments and who think NWBO will not be successful. That statement was by no means meant as a pumping statement. I do not think that any posts have any influence on the SP. The Market Makers and traders who have no long intentions with NWBO are in full control of that. That is just the fate of being on an OTC exchange.
One of the professional investment advisors in Biotech that I have had the fortune to meet through my own investment advisor mentioned something very interesting to me last week. I am paraphrasing his statement.
"At this time, everyone involved with the DCVax-L trial knows the results by now. There's been zero PR's from NWBO that were not very specific and to the point about the events they have PR'ed. Absolutely zero pumping from the management. If the results were questionable, there would have been PR's with a positive slant in order to 'prime' the market to look at the results in a positive light. We have seen that with almost all the companies who have questionable results they have tried to spin in a positive way. That is Biotech 101. When is the only time you don't feel a need to prime the market? When you are sitting on results that you feel is a home run."
Looking at the financing since DL, it is interesting to see that they have preferred short term deals with no or very limited dilution and whatever dilution will come in the form of discounts on shares AFTER announcements of results. The financing have been done with the acknowledgement that the short term share price is not important to them, as it has no influence on the terms of the financing. Even though they have made the decision not to worry about the short term SP, everything they have done on the financial side has not been linked to the pre-TLD share price.
This is just my opinion so feel free to disagree. We all have different views and opinions which is great. If you don't agree with any of the above, feel free to scroll on.....
